Review
Open access
Oct 2026
Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study.
OBJECTIVE To explore the knowledge, attitudes, and experiences of advanced ovarian cancer patients and clinicians regarding homologous recombination deficiency (HRD) testing in Canada to offer a more comprehensive understanding of the real-world implications of HRD testing, and help improve patient-informed decision-ma...
Julia McKenna, Rachelle Payandeh, Yelena Aizenberg et al.
· Patient Education and Counse... · 0 citations